FDA Cleared Proton Therapy System Tailored to Fit Linac-Like Vaults

Build Your Proton Center
Without Building A Proton Center

Industry opinion leaders say

  • Hanne M. Kooy, Ph.D.

    Associate Professor of Radiation Oncology, Massachusetts General Hospital

    “Adaptive therapy approach combined with a proton beam scanning is a quantum leap in our ability to cure cancer patients with radiation.”

  • Zelig A. Tochner, MD

    Former Emeritus Professor of Radiation Oncology, University of Pennsylvania

    “P-Cure’s gantry-less system can significantly reduce the cost of the initial investment required to establish proton therapy services.”

  • William F. Hartsell, MD

    Radiation Oncologist & Medical Director, Chicago Proton Center Radiation Oncology

    "We expect that imaging lung cancer patients in the upright position will allow us to more precisely target the tumor when we treat it with proton therapy.”

The Clinical Benefits, Together With Capital Cost Reduction, Will Enable a New Era of Widespread Proton Therapy

About P-Cure

Founded in 2007, P-Cure is at the forefront of democratizing Proton Therapy, offering the most compact FDA-cleared solution for treating cancer patients. Our comprehensive system enables the planning and treatment of patients with Proton Therapy in both supine and seated positions, tailored to fit linac-like vaults within existing or new radiation therapy centers.

Operating globally with headquarter in Switzerland; production and R&D platforms in the US, Israel, and China; global sales company and global service company in Singapore. We are in the process of setting up a helium ion R&D center in the US and adding a factory and R&D center in Singapore. P-Cure collaborates closely with healthcare providers supporting them in achieving unprecedented return on investment with operating breakeven typically within a year of implementation.

P-Cure is dedicated to ushering in a new era of life-saving technology accessible to all oncology centers and their patients, revolutionizing the cancer treatment landscape worldwide.

Stay Updated

Sign up to our Newsletter